These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33422503)

  • 1. Potential effective inhibitory compounds against Prostate Specific Membrane Antigen (PSMA): A molecular docking and molecular dynamics study.
    Nikfarjam Z; Bavi O; Amini SK
    Arch Biochem Biophys; 2021 Mar; 699():108747. PubMed ID: 33422503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptide inhibitors of the prostate specific membrane antigen (PSMA): A comparison of urea and thiourea derivatives.
    Young JD; Ma MT; Eykyn TR; Atkinson RA; Abbate V; Cilibrizzi A; Hider RC; Blower PJ
    Bioorg Med Chem Lett; 2021 Jun; 42():128044. PubMed ID: 33865971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.
    Bakht MK; Hayward JJ; Shahbazi-Raz F; Skubal M; Tamura R; Stringer KF; Meister D; Venkadakrishnan VB; Xue H; Pillon A; Stover M; Tronchin A; Fifield BA; Mader L; Ku SY; Cheon GJ; Kang KW; Wang Y; Dong X; Beltran H; Grimm J; Porter LA; Trant JF
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35064078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands.
    Subedi M; Minn I; Chen J; Kim Y; Ok K; Jung YW; Pomper MG; Byun Y
    Eur J Med Chem; 2016 Aug; 118():208-218. PubMed ID: 27128184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (
    Duan X; Liu F; Kwon H; Byun Y; Minn I; Cai X; Zhang J; Pomper MG; Yang Z; Xi Z; Yang X
    J Med Chem; 2020 Apr; 63(7):3563-3576. PubMed ID: 32207938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine-based asymmetric urea ligand for prostate carcinoma: Tuning biological efficacy through in silico studies.
    Sengupta S; Krishnan MA; Pandit A; Dudhe P; Sharma R; Chelvam V
    Bioorg Chem; 2019 Oct; 91():103154. PubMed ID: 31404798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic radiosynthesis of a
    Lowe PT; Dall'Angelo S; Fleming IN; Piras M; Zanda M; O'Hagan D
    Org Biomol Chem; 2019 Feb; 17(6):1480-1486. PubMed ID: 30681115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen.
    Mosayebnia M; Hajimahdi Z; Beiki D; Rezaeianpour M; Hajiramezanali M; Geramifar P; Sabzevari O; Amini M; Hatamabadi D; Shahhosseini S
    Bioorg Chem; 2020 Jun; 99():103743. PubMed ID: 32217372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen.
    Kim K; Kwon H; Barinka C; Motlova L; Nam S; Choi D; Ha H; Nam H; Son SH; Minn I; Pomper MG; Yang X; Kutil Z; Byun Y
    J Med Chem; 2020 Mar; 63(6):3261-3273. PubMed ID: 32097010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of human glutamate carboxypeptidases II and III reveals their divergent substrate specificities.
    Navrátil M; Tykvart J; Schimer J; Pachl P; Navrátil V; Rokob TA; Hlouchová K; Rulíšek L; Konvalinka J
    FEBS J; 2016 Jul; 283(13):2528-45. PubMed ID: 27208881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low molecular weight PSMA-based fluorescent imaging agent for cancer.
    Chen Y; Dhara S; Banerjee SR; Byun Y; Pullambhatla M; Mease RC; Pomper MG
    Biochem Biophys Res Commun; 2009 Dec; 390(3):624-9. PubMed ID: 19818734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
    Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
    Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PMPA for nephroprotection in PSMA-targeted radionuclide therapy of prostate cancer.
    Kratochwil C; Giesel FL; Leotta K; Eder M; Hoppe-Tich T; Youssoufian H; Kopka K; Babich JW; Haberkorn U
    J Nucl Med; 2015 Feb; 56(2):293-8. PubMed ID: 25613537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of a novel BODIPY-labeled PSMA inhibitor.
    Son SH; Kwon H; Ahn HH; Nam H; Kim K; Nam S; Choi D; Ha H; Minn I; Byun Y
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126894. PubMed ID: 31874825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 123I-MIP-1072, a small-molecule inhibitor of prostate-specific membrane antigen, is effective at monitoring tumor response to taxane therapy.
    Hillier SM; Kern AM; Maresca KP; Marquis JC; Eckelman WC; Joyal JL; Babich JW
    J Nucl Med; 2011 Jul; 52(7):1087-93. PubMed ID: 21680691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA.
    Ivanenkov YA; Machulkin AE; Garanina AS; Skvortsov DA; Uspenskaya AA; Deyneka EV; Trofimenko AV; Beloglazkina EK; Zyk NV; Koteliansky VE; Bezrukov DS; Aladinskaya AV; Vorobyeva NS; Puchinina MM; Riabykh GK; Sofronova AA; Malyshev AS; Majouga AG
    Bioorg Med Chem Lett; 2019 May; 29(10):1246-1255. PubMed ID: 30904185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase.
    Davis MI; Bennett MJ; Thomas LM; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5981-6. PubMed ID: 15837926
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Xu X; Zhang J; Hu S; He S; Bao X; Ma G; Luo J; Cheng J; Zhang Y
    Nucl Med Biol; 2017 May; 48():69-75. PubMed ID: 28273495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
    Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
    Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.